⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BFRI News
Biofrontera Inc. Common Stock
Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
globenewswire.com
BFRI
Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025
globenewswire.com
BFRI
Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG
globenewswire.com
BFRI
Biofrontera Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
globenewswire.com
BFRI